Bristol-Myers Profit Misses Estimates as New Drugs Get Attention

Bristol-Myers Profit Misses Estimates as New Drugs Get Attention

Robert Bruschini/Bristol Myers Squib via Bloomberg

Sales of Yervoy, approved in 2011, increased 49 percent to $229 million in the quarter, the company reported.